Chugai Pharmabody Research

Chugai Pharmabody Research company information, Employees & Contact Information

In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.
Looking for a particular Chugai Pharmabody Research employee's phone or email?

Chugai Pharmabody Research Questions

News

Japan's Chugai to position Singapore subsidiary as permanent global drug discovery research centre - BioSpectrum Asia

Japan's Chugai to position Singapore subsidiary as permanent global drug discovery research centre BioSpectrum Asia

Chugai and GSK collaborate to advance AID-351 for dengue - BioWorld MedTech

Chugai and GSK collaborate to advance AID-351 for dengue BioWorld MedTech

Chugai Pharmaceutical Co. - Singapore Economic Development Board (EDB)

Chugai Pharmaceutical Co. Singapore Economic Development Board (EDB)

How this S’pore lab accelerates discovery and approval of a new therapy for rare blood disorder - The Straits Times

How this S’pore lab accelerates discovery and approval of a new therapy for rare blood disorder The Straits Times

Chugai Pharma Opens $200m Antibody Lab In Singapore - Asian Scientist Magazine

Chugai Pharma Opens $200m Antibody Lab In Singapore Asian Scientist Magazine

A*STAR & Chugai collaborate on therapeutic antibody to fight COVID-19 - Agency for Science, Technology and Research

A*STAR & Chugai collaborate on therapeutic antibody to fight COVID-19 Agency for Science, Technology and Research

Chugai extends R&D collaboration in Singapore earmarking S$282M over next 5 years - BioSpectrum Asia

Chugai extends R&D collaboration in Singapore earmarking S$282M over next 5 years BioSpectrum Asia

A digitalisation boost to its global pharmaceutical aspirations - CNA

A digitalisation boost to its global pharmaceutical aspirations CNA

Chugai and GSK sign collaboration agreement for anti-dengue virus antibody AID351 - BioSpectrum Asia

Chugai and GSK sign collaboration agreement for anti-dengue virus antibody AID351 BioSpectrum Asia

Healthcare innovations shaping a healthier future from Singapore - Singapore Economic Development Board (EDB)

Healthcare innovations shaping a healthier future from Singapore Singapore Economic Development Board (EDB)

Top Chugai Pharmabody Research Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant